Carcinoembryonic Antigen Serum Levels in Nonmelanoma Skin Cancer

Background: Carcinoembryonic antigen (CEA) is a glycoprotein, which is present in the foetal colon, some benign conditions and different malignancies, particularly in colon adenocarcinoma. We focused this study on non-melanoma skin cancer (NMSC). NMSC is a common malignancy and it is an important so...

Full description

Bibliographic Details
Main Authors: Saverio Latteri, Vito Emanuele Catania, Giulia Malaguarnera, Andrea Peri, Gaetano Bertino, Giuseppe Frazzetto, Antonio Maria Borzì, Antonio Biondi, Rosario Emanuele Perrotta, Michele Malaguarnera
Format: Article
Language:English
Published: MDPI AG 2018-02-01
Series:Biomedicines
Subjects:
Online Access:http://www.mdpi.com/2227-9059/6/1/24
_version_ 1819090279917944832
author Saverio Latteri
Vito Emanuele Catania
Giulia Malaguarnera
Andrea Peri
Gaetano Bertino
Giuseppe Frazzetto
Antonio Maria Borzì
Antonio Biondi
Rosario Emanuele Perrotta
Michele Malaguarnera
author_facet Saverio Latteri
Vito Emanuele Catania
Giulia Malaguarnera
Andrea Peri
Gaetano Bertino
Giuseppe Frazzetto
Antonio Maria Borzì
Antonio Biondi
Rosario Emanuele Perrotta
Michele Malaguarnera
author_sort Saverio Latteri
collection DOAJ
description Background: Carcinoembryonic antigen (CEA) is a glycoprotein, which is present in the foetal colon, some benign conditions and different malignancies, particularly in colon adenocarcinoma. We focused this study on non-melanoma skin cancer (NMSC). NMSC is a common malignancy and it is an important source of morbidity and death in the world. In this study we evaluated whether CEA level increases in NMSC. Patients and Methods: A total of 566 patients with non-melanoma skin cancer (NMSC) were enrolled; 286 patients with NMSC showed CEA levels above normal values, and 280 showed CEA levels below normal values. Patients with high levels of CEA underwent abdominal ultrasound, gastro endoscopy, colonoscopy, and abdominal CT scans. Results: We studied 566 patients, 286 were positive to CEA and 280 were negative. Of the 286 patients positive to CEA, 132 had basal cell carcinoma (64 patients had an associated cancer) and 154 had squamous cell carcinoma (75 patients were affected by cancer). Of the 280 patients negative to CEA, 130 had basal cell carcinoma (12 were associated with cancer), and 150 had squamous cell carcinoma (18 were associated with cancer). The mean age of the 566 case control subjects were 65–81 years. Of the 10 subjects that were the positive control for CEA, two had cancer. Of the 556 subjects that were the negative control for CEA, three had cancer. Conclusions: In patients that present high serum levels of CEA, we give attention to adenocarcinoma tumour first. The pattern of association may be attributable to bias because the group with NMSC were frequently evaluated than those with no history of NMSC. Our results showed that out of 286 patients that were CEA-positive, 139 had cancer, and of the 280 that were CEA-negative, 30 had cancer. Therefore, 20% of patients do not follow the trend. Other markers should be investigated.
first_indexed 2024-12-21T22:21:19Z
format Article
id doaj.art-1ea7b39979914222a51972d8774ac151
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-12-21T22:21:19Z
publishDate 2018-02-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-1ea7b39979914222a51972d8774ac1512022-12-21T18:48:19ZengMDPI AGBiomedicines2227-90592018-02-01612410.3390/biomedicines6010024biomedicines6010024Carcinoembryonic Antigen Serum Levels in Nonmelanoma Skin CancerSaverio Latteri0Vito Emanuele Catania1Giulia Malaguarnera2Andrea Peri3Gaetano Bertino4Giuseppe Frazzetto5Antonio Maria Borzì6Antonio Biondi7Rosario Emanuele Perrotta8Michele Malaguarnera9Department of Medical, Surgical Sciences and Advanced Technologies “G.F. Ingrassia”, University of Catania, 95123 Catania, ItalyDepartment of Medical, Surgical Sciences and Advanced Technologies “G.F. Ingrassia”, University of Catania, 95123 Catania, ItalyDepartment of Biomedical and Biotechnological Science, University of Catania, 95123 Catania, ItalyDepartment of General Surgery, Policlinico “San Matteo”, University of Pavia, 27100 Pavia, ItalyHepatology Unit, Department of Clinical and Experimental Medicine, University of Catania, 95123 Catania, ItalyResearch Centre “The Great Senescence”, University of Catania, 95120 Catania, ItalyResearch Centre “The Great Senescence”, University of Catania, 95120 Catania, ItalyDepartment of General Surgery and Medical-Surgery Specialties, University of Catania, 95100 Catania, ItalyDepartment of General Surgery and Medical-Surgery Specialties, University of Catania, 95100 Catania, ItalyDepartment of Biomedical and Biotechnological Science, University of Catania, 95123 Catania, ItalyBackground: Carcinoembryonic antigen (CEA) is a glycoprotein, which is present in the foetal colon, some benign conditions and different malignancies, particularly in colon adenocarcinoma. We focused this study on non-melanoma skin cancer (NMSC). NMSC is a common malignancy and it is an important source of morbidity and death in the world. In this study we evaluated whether CEA level increases in NMSC. Patients and Methods: A total of 566 patients with non-melanoma skin cancer (NMSC) were enrolled; 286 patients with NMSC showed CEA levels above normal values, and 280 showed CEA levels below normal values. Patients with high levels of CEA underwent abdominal ultrasound, gastro endoscopy, colonoscopy, and abdominal CT scans. Results: We studied 566 patients, 286 were positive to CEA and 280 were negative. Of the 286 patients positive to CEA, 132 had basal cell carcinoma (64 patients had an associated cancer) and 154 had squamous cell carcinoma (75 patients were affected by cancer). Of the 280 patients negative to CEA, 130 had basal cell carcinoma (12 were associated with cancer), and 150 had squamous cell carcinoma (18 were associated with cancer). The mean age of the 566 case control subjects were 65–81 years. Of the 10 subjects that were the positive control for CEA, two had cancer. Of the 556 subjects that were the negative control for CEA, three had cancer. Conclusions: In patients that present high serum levels of CEA, we give attention to adenocarcinoma tumour first. The pattern of association may be attributable to bias because the group with NMSC were frequently evaluated than those with no history of NMSC. Our results showed that out of 286 patients that were CEA-positive, 139 had cancer, and of the 280 that were CEA-negative, 30 had cancer. Therefore, 20% of patients do not follow the trend. Other markers should be investigated.http://www.mdpi.com/2227-9059/6/1/24carcinoembryonic antigennon-melanoma skin cancersynchronous tumourmetachronous tumourmultiple tumours
spellingShingle Saverio Latteri
Vito Emanuele Catania
Giulia Malaguarnera
Andrea Peri
Gaetano Bertino
Giuseppe Frazzetto
Antonio Maria Borzì
Antonio Biondi
Rosario Emanuele Perrotta
Michele Malaguarnera
Carcinoembryonic Antigen Serum Levels in Nonmelanoma Skin Cancer
Biomedicines
carcinoembryonic antigen
non-melanoma skin cancer
synchronous tumour
metachronous tumour
multiple tumours
title Carcinoembryonic Antigen Serum Levels in Nonmelanoma Skin Cancer
title_full Carcinoembryonic Antigen Serum Levels in Nonmelanoma Skin Cancer
title_fullStr Carcinoembryonic Antigen Serum Levels in Nonmelanoma Skin Cancer
title_full_unstemmed Carcinoembryonic Antigen Serum Levels in Nonmelanoma Skin Cancer
title_short Carcinoembryonic Antigen Serum Levels in Nonmelanoma Skin Cancer
title_sort carcinoembryonic antigen serum levels in nonmelanoma skin cancer
topic carcinoembryonic antigen
non-melanoma skin cancer
synchronous tumour
metachronous tumour
multiple tumours
url http://www.mdpi.com/2227-9059/6/1/24
work_keys_str_mv AT saveriolatteri carcinoembryonicantigenserumlevelsinnonmelanomaskincancer
AT vitoemanuelecatania carcinoembryonicantigenserumlevelsinnonmelanomaskincancer
AT giuliamalaguarnera carcinoembryonicantigenserumlevelsinnonmelanomaskincancer
AT andreaperi carcinoembryonicantigenserumlevelsinnonmelanomaskincancer
AT gaetanobertino carcinoembryonicantigenserumlevelsinnonmelanomaskincancer
AT giuseppefrazzetto carcinoembryonicantigenserumlevelsinnonmelanomaskincancer
AT antoniomariaborzi carcinoembryonicantigenserumlevelsinnonmelanomaskincancer
AT antoniobiondi carcinoembryonicantigenserumlevelsinnonmelanomaskincancer
AT rosarioemanueleperrotta carcinoembryonicantigenserumlevelsinnonmelanomaskincancer
AT michelemalaguarnera carcinoembryonicantigenserumlevelsinnonmelanomaskincancer